Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-22T17:40:08.388Z Has data issue: false hasContentIssue false
  • English
  • Français

Aspects of tyrosine metabolism in schizophrenia

Published online by Cambridge University Press:  09 July 2009

C. H. Williams
C. H. Williams
Affiliation:
Department of Mental Health, Queen's University of Belfast, Belfast
Get access Rights & Permissions [Opens in a new window]

Synopsis

Disordered amine metabolism is frequently suggested as being of aetiological significance in schizophrenia. The present study investigates the effects of loading doses of the cate-cholamine precursor L-tyrosine in this illness. Groups of schizophrenic and control subjects were given loading doses of L-tyrosine after which plasma tyrosine levels and excretion of some tyrosine metabolities were measured. In only one parameter, excretion of free p-hydroxyphenylacetic acid, was any significant difference observed between the groups. The study is discussed in relation to some of the biochemical theories advanced from time to time for schizophrenia.

Type
Research Article
Information
Psychological Medicine , Volume 1 , Issue 4 , August 1971 , pp. 286 - 291
Copyright
Copyright © Cambridge University Press 1971

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Bell, C. E., and Somerville, A. R. (1966). Identity of the ‘pink spot’. Nature, 211, 1405–1406.CrossRefGoogle ScholarPubMed
Boulton, A. A., Pollit, R. J., and Majer, J. R. (1967). The identity of a urinary ‘pink spot’ in schizophrenia and Parkinson's disease. Nature, 215, 132–134.CrossRefGoogle ScholarPubMed
De Boer, T. J., and Backer, H. J. (1954). A new method for the preparation of diazo-methane. Recueil des travaux chimiques des Pays-bas, 73, 229–234.CrossRefGoogle Scholar
Friedhoff, A. J., and Van Winkle, E. (1963). A method for the detection of β-phenylethylamines and β-phenylethylamino acids. Journal of Chromatography, 11, 272–274.CrossRefGoogle ScholarPubMed
Greiner, A. C. (1967). Schizophrenia—melanosis: side effect or basic defect? In Molecular Basis of Some Aspects of Mental Activity. Edited by Walaas, O.. Volume 2. Pp. 187–189. Academic Press: London.Google Scholar
Kakimoto, Y., and Armstrong, M. D. (1962). The phenolic amines of human urine. Journal of Biological Chemistry, 237, 208214CrossRefGoogle ScholarPubMed
Kety, S. S. (1967). Catecholamines in neuropsychiatric states. In Molecular Basis of Some Aspects of Mental Activity. Edited by Walaas, O.. Volume 2. Pp. 193203. Academic Press: London.Google Scholar
Michaux, R. (1968). Recèrche des catabolites urinaires éventuellement caractéristiques de la schizophrénie. Pathologie-Biologie, 16, 731–734.Google Scholar
Poisner, A. M. (1960). Serum Phenylalanine in schizophrenia: biochemical genetic aspects. Journal of Nervous and Mental Disease, 131, 74–76.CrossRefGoogle ScholarPubMed
Pollin, W., Cardon, P. V. Jr., and Kety, S. S. (1961). Effects of amino acid feedings in schizophrenic patients treated with Iproniazid. Science, 133, 104–105.CrossRefGoogle ScholarPubMed
Russell, G. F. M. (1960). Dietetic treatment of patients with anorexia nervosa. Nutrition, 14, 14.Google Scholar
Smith, I. (1960). Chromatographic and Electrophoretic Techniques. 2nd ed. Volume 1. Heinemann: London.Google Scholar
Sober, H. A. (1968). Handbook of Biochemistry. The Chemical Rubber Co.: Cleveland.Google Scholar
Udenfriend, S. (1962). Flourescence Assay in Biology and Medicine. Academic Press: New York.Google Scholar
Williams, C. H., Gibson, J. G., and McCormick, W. O. (1966). 3, 4-dimethoxyphenylethylamine in Schizophrenia. Nature, 211, 1195.CrossRefGoogle ScholarPubMed
Williams, C. M., and Sweeley, C. C. (1964). Gas chromatography of urinary aromatic acids. In Biomedical Applications of Gas Chromatography. Pp. 225–269. Edited by Szymanski, H. A.. Plenum Press: New York.Google Scholar